Resumen
Antibody?Drug Conjugate (ADC) is a novel therapy that has revolutionized the treatment of human cancers. In this review, we focus on the role of ADC in lymphoid malignancies. We summarize the latest advances of ADC development, and we discuss the landmark and most updated clinical trials.